Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2.
Saved in:
| Title: | Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2. |
|---|---|
| Authors: | Driouich JS; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France. Electronic address: jean-selim.driouich@univ-amu.fr., Cochin M; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Touret F; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Petit PR; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Gilles M; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Moureau G; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Barthélémy K; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Laprie C; Laboratoire Vet-Histo, Marseille, France., Wattanakul T; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Chotsiri P; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Hoglund RM; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Tarning J; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom., Fraisse L; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Sjö P; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Mowbray CE; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Escudié F; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Scandale I; Drugs for Neglected Diseases initiative, Geneva, Switzerland., Chatelain E; Drugs for Neglected Diseases initiative, Geneva, Switzerland., de Lamballerie X; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France., Solas C; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France; APHM, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France., Nougairède A; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France. |
| Source: | EBioMedicine [EBioMedicine] 2022 Aug; Vol. 82, pp. 104148. Date of Electronic Publication: 2022 Jul 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35834886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Driouich+JS%22">Driouich JS</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France. Electronic address: jean-selim.driouich@univ-amu.fr.<br /><searchLink fieldCode="AU" term="%22Cochin+M%22">Cochin M</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Touret+F%22">Touret F</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Petit+PR%22">Petit PR</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Gilles+M%22">Gilles M</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Moureau+G%22">Moureau G</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Barthélémy+K%22">Barthélémy K</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Laprie+C%22">Laprie C</searchLink>; Laboratoire Vet-Histo, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Wattanakul+T%22">Wattanakul T</searchLink>; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Chotsiri+P%22">Chotsiri P</searchLink>; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Hoglund+RM%22">Hoglund RM</searchLink>; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tarning+J%22">Tarning J</searchLink>; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fraisse+L%22">Fraisse L</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sjö+P%22">Sjö P</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mowbray+CE%22">Mowbray CE</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Escudié+F%22">Escudié F</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Scandale+I%22">Scandale I</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chatelain+E%22">Chatelain E</searchLink>; Drugs for Neglected Diseases initiative, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Solas+C%22">Solas C</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France; APHM, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Nougairède+A%22">Nougairède A</searchLink>; Unité des Virus Émergents (UVE: Aix-Marseille University -IRD 190-Inserm 1207), Marseille, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2022 Aug; Vol. 82, pp. 104148. <i>Date of Electronic Publication: </i>2022 Jul 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35834886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ebiom.2022.104148 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104148 Titles: – TitleFull: Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Driouich JS – PersonEntity: Name: NameFull: Cochin M – PersonEntity: Name: NameFull: Touret F – PersonEntity: Name: NameFull: Petit PR – PersonEntity: Name: NameFull: Gilles M – PersonEntity: Name: NameFull: Moureau G – PersonEntity: Name: NameFull: Barthélémy K – PersonEntity: Name: NameFull: Laprie C – PersonEntity: Name: NameFull: Wattanakul T – PersonEntity: Name: NameFull: Chotsiri P – PersonEntity: Name: NameFull: Hoglund RM – PersonEntity: Name: NameFull: Tarning J – PersonEntity: Name: NameFull: Fraisse L – PersonEntity: Name: NameFull: Sjö P – PersonEntity: Name: NameFull: Mowbray CE – PersonEntity: Name: NameFull: Escudié F – PersonEntity: Name: NameFull: Scandale I – PersonEntity: Name: NameFull: Chatelain E – PersonEntity: Name: NameFull: de Lamballerie X – PersonEntity: Name: NameFull: Solas C – PersonEntity: Name: NameFull: Nougairède A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2352-3964 Numbering: – Type: volume Value: 82 Titles: – TitleFull: EBioMedicine Type: main |
| ResultId | 1 |